178 related articles for article (PubMed ID: 31255807)
1. Combined Effects of Alcohol and Metabolic Disorders in Patients With Chronic Liver Disease.
Åberg F; Puukka P; Salomaa V; Männistö S; Lundqvist A; Valsta L; Perola M; Jula A; Färkkilä M
Clin Gastroenterol Hepatol; 2020 Apr; 18(4):995-997.e2. PubMed ID: 31255807
[TBL] [Abstract][Full Text] [Related]
2. Interaction Between Alcohol Use and Metabolic Risk Factors for Liver Disease: A Critical Review of Epidemiological Studies.
Åberg F; Färkkilä M; Männistö V
Alcohol Clin Exp Res; 2020 Feb; 44(2):384-403. PubMed ID: 31854001
[TBL] [Abstract][Full Text] [Related]
3. Synergistic and Detrimental Effects of Alcohol Intake on Progression of Liver Steatosis.
Di Ciaula A; Bonfrate L; Krawczyk M; Frühbeck G; Portincasa P
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269779
[TBL] [Abstract][Full Text] [Related]
4. Dual alcohol and metabolic-related liver disease: Results from a population of liver transplant patients.
Erard D; Villeret F; Chouik Y; Guillaud O; Scoazec JY; Caussy C; Disse E; Boillot O; Hervieu V; Dumortier J
Liver Int; 2024 Feb; 44(2):422-432. PubMed ID: 38010979
[TBL] [Abstract][Full Text] [Related]
5. Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.
Yang KC; Hung HF; Lu CW; Chang HH; Lee LT; Huang KC
Sci Rep; 2016 Jun; 6():27034. PubMed ID: 27246655
[TBL] [Abstract][Full Text] [Related]
6. The Association Between Nonalcoholic Fatty Liver Disease and Metabolic Abnormalities in The United States Population.
Jinjuvadia R; Antaki F; Lohia P; Liangpunsakul S
J Clin Gastroenterol; 2017 Feb; 51(2):160-166. PubMed ID: 27580477
[TBL] [Abstract][Full Text] [Related]
7. Association of epicardial fat volume and nonalcoholic fatty liver disease with metabolic syndrome: From the CAESAR study.
Kim BJ; Kim HS; Kang JG; Kim BS; Kang JH
J Clin Lipidol; 2016; 10(6):1423-1430.e1. PubMed ID: 27919360
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of alcoholic and nonalcoholic fatty liver disease in China.
Fan JG
J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():11-7. PubMed ID: 23855290
[TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients.
Ortolan A; Lorenzin M; Tadiotto G; Russo FP; Oliviero F; Felicetti M; D'Incà R; Favero M; Piaserico S; Doria A; Ramonda R
Clin Rheumatol; 2019 Oct; 38(10):2843-2850. PubMed ID: 31254236
[TBL] [Abstract][Full Text] [Related]
10. Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease.
Hagström H; Hegmar H; Moreno C
United European Gastroenterol J; 2024 Mar; 12(2):168-176. PubMed ID: 38381115
[TBL] [Abstract][Full Text] [Related]
11. Alcohol and Obesity: A Dangerous Association for Fatty Liver Disease.
Mahli A; Hellerbrand C
Dig Dis; 2016; 34 Suppl 1():32-9. PubMed ID: 27548267
[TBL] [Abstract][Full Text] [Related]
12. Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities.
Idalsoaga F; Kulkarni AV; Mousa OY; Arrese M; Arab JP
Front Med (Lausanne); 2020; 7():448. PubMed ID: 32974366
[TBL] [Abstract][Full Text] [Related]
13. The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease.
Díaz LA; Arab JP; Louvet A; Bataller R; Arrese M
Nat Rev Gastroenterol Hepatol; 2023 Dec; 20(12):764-783. PubMed ID: 37582985
[TBL] [Abstract][Full Text] [Related]
14. Is Nonalcoholic Fatty Liver Disease Indeed the Hepatic Manifestation of Metabolic Syndrome?
Katsiki N; Perez-Martinez P; Anagnostis P; Mikhailidis DP; Karagiannis A
Curr Vasc Pharmacol; 2018; 16(3):219-227. PubMed ID: 28669328
[TBL] [Abstract][Full Text] [Related]
15. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data.
Kabbany MN; Conjeevaram Selvakumar PK; Watt K; Lopez R; Akras Z; Zein N; Carey W; Alkhouri N
Am J Gastroenterol; 2017 Apr; 112(4):581-587. PubMed ID: 28195177
[TBL] [Abstract][Full Text] [Related]
17. Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern.
Dhamija E; Paul SB; Kedia S
Indian J Med Res; 2019 Jan; 149(1):9-17. PubMed ID: 31115369
[TBL] [Abstract][Full Text] [Related]
18. Identification of reciprocal causality between non-alcoholic fatty liver disease and metabolic syndrome by a simplified Bayesian network in a Chinese population.
Zhang Y; Zhang T; Zhang C; Tang F; Zhong N; Li H; Song X; Lin H; Liu Y; Xue F
BMJ Open; 2015 Sep; 5(9):e008204. PubMed ID: 26395497
[TBL] [Abstract][Full Text] [Related]
19. The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease.
Boyle M; Masson S; Anstee QM
J Hepatol; 2018 Feb; 68(2):251-267. PubMed ID: 29113910
[TBL] [Abstract][Full Text] [Related]
20. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
Streba LA; Vere CC; Rogoveanu I; Streba CT
World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
